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Abstract 
 Crimean- Congo Hemorrhagic Fever (CCHF) is a viral zoonotic tick-
born disease with a mortality rate of up to 50% in human. CCHF is caused 
by genus Nairovirus, in the family of Bunyaviridae, and can be transmitted 
to humans through the bite of ticks Hyalomma species or its contact with 
blood or tissues of CCHF patients or infected livestock. CCHF is a public 
health problem in many regions of the world e.g. Eastern Europe, Asia, 
Middle East, and Africa. The history of CCHF in Iraq shows that the disease 
has been detected in Iraq since 1979. During 2010-2011, five cases were 
referred to the infectious unit of Erbil teaching hospital on assumption of 
acute febrile illness, including some of them with hemorrhagic 
manifestations. Patients' serum samples were obtained at the time of 
admission and sent to the Central Public Health laboratory 
(CCHF.REF.LAB), Baghdad. Diagnosis was confirmed by ELISA for anti-
CCHFV IgM. However, all of them that handled livestock had accounts of 
slaughtering animals within two weeks before symptom onset ,and the most 
commonly encountered symptom and signs were fever , malaise(100%) 
,headache(80%) ,abdominal pain , myalgia, petechiae , ecchymosis(60%), 
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nausea, vomiting, bleeding from gastrointestinal system, gingival, nose and 
vagina .Others include thrombocytopenia(100%), elevated liver 
enzymes(S.ASTandS.ALT) 80%,prolonged prothrombin time, anemia ,and 
Albuminuria (60%). Patients were treated following strict infection 
prevention measures and supporting circulation using intravenous fluid, 
blood with blood product support (platelet and fresh frozen plasma), with 
specific treatment with ribavirin .Thus, all of them positively responded to 
the treatment, and was cured, and discharged home.  
 
Keywords: CCHF, Thrombocytopenia, Erbil. 
 
Introduction 
 Crimean-Congo hemorrhagic fever (CCHF) disease is one of the 
most virulent viral hemorrhagic fevers which are a life threatening disease 
reported in many countries in Europe, Asia and Africa (Williams RJ et al., 
2000; Chinikar Set al., 2009). CCHFV is a member of the Nairovirus genus 
of the family, Bunyaviridae (Whitehouse CA, 2003). CCHF was first 
recognized in the Crimean peninsula in the mid-1940s (Chinikar S et al., 
2009; Whitehouse CA, 2003). Crimean-Congo Hemorrhagic Fever (CCHF) 
virus causes a hemorrhagic and toxic syndrome disease in humans and high 
mortality rates of up to 50% (Lyudmila et al., 2003). An outbreak in China in 
1965 had a case fatality rate of 80%. A large number of cases have also been 
reported from Middle Eastern countries such as Iraq, United Arab Emirates, 
Saudi Arabia and Oman (Ergonul O, 2006). Since 2000, outbreaks of CCHF 
have been reported in Albania, Kosovo, Turkey, Pakistan, Iran, Mauritania, 
Kenya and Greece (S. Chinikara et al., 2010; Krauss, H. et al., 2003). 
 The occurrence of CCHF closely approximates the known 
distribution of Hyalomma spp. ticks. Humans become infected through the 
bites of ticks, or possibly by crushing engorged infected ticks, or by contact 
with blood or tissues from viremic livestock or by direct contact with a 
patient with CCHF during the acute phase of the infection which occurs 
primarily at the hospital (nosocomeal infection) and is generally 
characterized by more severe clinical symptoms and high mortality rate 
(Dorsten C et al. 2003; Ergonul O and Whitehouse CA, 2007; Flick R and 
Whitehouse CA, 2005). In Iraq, the Crimean-Congo Hemorrhagic Fever was 
unknown till September 1979, when a 24 years old lady was admitted to AL- 
yarmok hospital in Baghdad with bleeding tendency on the 7th of Sep.1979, 
and after 2 days, she died. After 4 days, the physician and one of the health 
workers who were in close contact with the patient developed fever, 
headache, and bleeding from gastrointestinal tract. Unfortunately, they died 
too. During that same year, 10 cases were reported (8 were female and 2 
were male) also; and seven out of ten died. All the cases were in contact with 
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animal except the physician and the health worker (Tantawi HH, 1980; Emad 
S. et al., 2012). Therefore, the objective of this paper is to show the 
epidemiologic, clinical, and laboratory outcome of patients with proven 
Crimean Congo Hemorrhagic Fever admitted to the infectious unit of Erbil 
teaching hospital during 2010 -2011. 
 
Patients and Methods 
 One case (September 2010) and four cases (June 2011) were referred 
to the infectious unit of Erbil Teaching Hospital on the assumption of acute 
febrile illness. All were treated as typhoid fever but in some cases, bleeding 
was present, and did not improve in any way. Patients with infection 
prevention protocol were admitted to our center, and detailed history was 
taken regarding residency, occupation and the animals they had contact with. 
The case definition for suspected cases included individuals who had fever, 
myalgia, malaise, diarrhea, history of tick bites, slaughtering of animal, 
contact with patients in acute cases and travel to endemic area. 
 The probable cases included patients who had leucopenia, 
thrombocytopenia, elevated liver enzymes (ALT, AST), Proteinuria and 
hematuria. Probable cases with the isolation of virus, Detection of antigen, or 
Detection of antibody were considered as CCHF confirmed cases (Emad S. 
et al., 2012). 
 Patients were admitted to the unit and complete investigation was 
done which includes complete blood count, blood film, renal function test, 
Liver function test, infectious panel including viral hepatitis (HAV, HBV, 
and HCV), HIV, typhoid fever, brucellosis, malaria, ANA and general urine 
examination, stool examination, Chest X-ray and blood culture. 
 Patients' serum samples were obtained at the time of admission and 
sent to Central Public Health laboratory (CCHF.REF.LAB), Baghdad. 
Diagnosis was confirmed by ELISA for anti-CCHFV IgM as described 
[CCHF IgM ELISA Kit National Institute for Comm. Dis. Special Pathogens 
Unit]. Patients were treated by supporting circulation via intravenous fluid, 
broad spectrum antibiotics and blood with blood product support (platelet 
and fresh frozen plasma), with specific treatment with Ribavirin for 10 days  
(30 mg/kg as an initial loading dose, then 15 mg/kg every six hours for four 
days, and then 7.5 mg/kg every 8 hours for six days). Patients were closely 
observed during admission (15-20 days). 
 
Results 
 There were five cases (four males and one female) with age ranging 
from 19 to50 years, and median age of 22 years. Three were from Erbil –
Soran, Majidawa and they were from one family, while one was from 
Khalifan –Gomazard and another was from Duhok –Bardarash and were all 
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referred to our center for management. Figure (1) shows geographic 
distribution of patients affected by CCHF (areas are marked yellow)( 
Wikipedia, the free encyclopedia. Erbil province. 
http://en.wikipedia.org/wiki/Arbil_Province)  (6th March, 2013). 
 
Figure (1) Geographic distribution of patients affected by CCHF. 
 
Table (1): Shows epidemiologic characteristics of confirmed cases of CCHF. 
Epidemiologic characteristics No.    (%) Total No.=5 
Sex Male 4 (80) Female 1 (20) 
 
Occupation 
House wife 1 (20) 
Student & worker 2 (40) 
Shepherd 1 (20) 
Cattleman 1 (20) 
Residency 
Erbil, Soran, Majidawa 3 (60) 
Erbil ,Khalifan, Gomazard 1 (20) 
Duhok, Khabate, Daratu 1 (20) 
Contact to animals* Yes 5 100) 
History of Slaughtering animal* Yes 5 (100) 
Type of animal at home(goat &cow) Yes 5 (100) 
Ticks on animal Yes 3(60) No 2    (40) 
* Within two weeks of symptom onset. 
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Regarding the occupation of patients, one of them was a shepherd 
and one was an auctioneer of goats and cows, two other male patients were 
students but were helping the shepherd sometimes, where as a female patient 
was a house wife but was dealing with animals at home. 
 As a matter of fact, all of them handled livestock and had the history 
of slaughtering animals within two weeks before symptom onset. Though, 
there were ticks on animals in Majidawa as shown in figure (2), none of 
them described tick bite, none of the family members of all the patients were 
affected, and there was no history of travel outside the area where they are 
residing or other histories as reported in the previous case. 
 
Figure (2): Ticks on infected cows from Majidawa. 
 
 Symptoms and signs observed in patients are shown in the table 
(2).The most commonly encountered signs and symptoms were fever, 
malaise, headache, abdominal pain, myalgia, nausea, vomiting, petechiae , 
ecchymosis (figure -3) and bleeding from gastrointestinal system, gingiva , 
nose and vagina. 
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Table (2): Symptoms and signs of confirmed cases of CCHF. 
Symptom and Signs No. (%) Total No. = 5 
Fever 5 (100) 
Malaise 5 (100) 
Headache 4 (80) 
Hematuria 4 (80) 
Melena 4 (80) 
Hypotension 3 (60) 
Abdominal pain 3 (60) 
Petechiae-ecchymosis 3 (60) 
Myalgia 3 (60) 
Bleeding from puncture  sites 2 (40) 
Nausea and vomiting 2 (40) 
Epistaxis 2 (40) 
Splenomegally 2 (40) 
Hematamesis 1 (20) 
Vaginal bleeding 1 (20) 
Gum bleeding 1 (20) 
Arthralgia 1 (20) 
Hepatomegaly 1 (20) 
 
Figure (3): shows patient with ecchymosis. 
 
 Serologic test results for hepatitis A, B, C viruses (HAV, HBV, and 
HCV), HIV, Brucella and Typhoid fever were negative .Anti nuclear 
antibody, malaria peripheral blood smear examinations and bacterial blood 
cultures were negative too. 
 Abnormal laboratory test results are shown in table (3). However, 
diagnosis of CCHF was confirmed by ELISA for anti-CCHFV IgM. 
Complete blood counts showed thrombocytopenia in all patients (median 18 
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x 103/ML, range: 2–31 x 103/ML), leucopenia in 2/5 (median 4000/ML, 
range 2000–8000/ML), and anemia in 3out of 5 patients (median 9.8g/dL, 
range 6.1–14 g/dL). Serum aspartate aminotransferase (AST) (median 120 
U/L, range 80–250U/L), alanine aminotransferase (ALT) (median 140 U/L, 
range 66–260 U/L, Alkaline  phosphates, renal function test and blood 
glucose were  within normal ranges for all patients .  Coagulation tests 
showed prolonged prothrombin time (PT) (median 14.5 second, range 14.1–
22.5 second) and activated partial thromboplastin time (aPTT) (median 36.9 
second, range 33.2–59.1 second) in 2out of 5patients. Also, urine 
examination showed RBC   in 4 patients and Albuminuria in 3 patients.  
Table (3): Laboratory parameters of confirmed cases of CCHF. 
 
Laboratory parameters 
No. (%) 
Total No. = 5 
CCHF virus  IgM (Positive) 5 (100) 
Thrombocytopenia 5 (100) 
RBC  in urine 4 (80) 
RBC  in stool 4 (80) 
S AST(elevated ) 4 (80) 
SALT(elevated ) 4 (80) 
PT(prolonged ) 3 (60) 
Anemia 3 (60) 
Albuminuria 3 (60) 
APTT(prolonged ) 2 (40) 
Leucopenia 2 (40) 
 
  Patients were treated in isolated room following strict infection 
prevention measures and supporting circulation by intravenous fluid, broad 
spectrum antibiotics and blood with blood product support (platelet and fresh 
frozen plasma), with specific treatment with ribavirin for 10 days (30 mg/kg 
as an initial loading dose, then 15 mg/kg every six hours for four days, and 
then 7.5 mg/kg every 8 hours for six days).Thus, all of them positively 
responded to the treatment, and was cured after being admitted (within 15-20 
days),and then were discharged home. When they were followed up by 
telephone, they were still doing very well. The veterinary team from the 
directorate of health visited the sector and village of the affected patients, 
and they checked animals and gave those appropriate instructions and proper 
management. 
 
Discussion  
 This study shows the epidemiologic, clinical, and laboratory outcome 
of patients diagnosed with CCHF.Cases were found in rural area where 
animals were kept at home and had direct contact with infected goats and 
cows which act as livestock for CCHF virus. Table (1) demonstrated that the 
main route of transmission of CCHF was through handling blood and tissues 
European Scientific Journal   August  2014 edition vol.10, No.24   ISSN: 1857 – 7881 (Print)  e - ISSN 1857- 7431 
226 
of slaughtered viremic livestock at home. Though, they slaughtered sheep in 
their house, none of them had tick bite. It is clear that when livestock and 
other hosts are in the viremic period, they are dangerous for transmission of 
CCHFV to human and this is the main route of transmission of Crimean 
Congo Hemorrhagic Fever Virus in Iraq, Iran and Turkey (Chinikar S et al., 
2009; S. Chinikara et al., 2010; Emad S. et al., 2012; S. Sami Kartiet al., 
2004). In addition, it could also affect neighboring countries where such 
animals have been transported to. The most common clinical signs and 
symptoms reported in CCHF are fever, myalgia, malaise, headache, nausea, 
vomiting, diarrhea, abdominal pain, petechiae, ecchymosis, and visceral 
bleeding. Most of these signs and symptoms were also observed in our 
patients (S. Sami Karti et al., 2004). 
  Prolongation of PT and PTT was thought to be caused by liver 
damage. Of the viral hemorrhagic fevers, CCHF infection has the most florid 
hemorrhage and highest frequency of large ecchymosis. Besides elevated PT, 
A-PTT, and thrombocytopenia, damage to vascular endothelium directly by 
the virus and cytokine storm can lead to bleeding tendencies(S. Sami Karti et 
al. ,2004; Peters CJ. et al. ,2002  ;Burt FJ. et al. ,1997;Swanepoel R et al. 
,1989). 
 Overall laboratory findings in our patients were consistent with the 
findings of other CCHF case series. Liver transaminases levels were high in 
our patients, beside the hepatic vascular involvement and resulting 
infarctions in liver parenchyma. Also, direct Hepatocellular involvement 
may also be responsible for elevated serum aminotransferase (Peters CJ. et 
al., 2002; Swanepoel R et al., 1989).Mortality rates for various CCHF 
outbreaks have varied greatly. The average fatality rate is often 30–50 %( S. 
Sami Karti et al., 2004; Burt FJ. et al. ,1997)but mortality rates from 10% to 
80% have been reported in various outbreaks, e.g. 72.7% and 80% from the 
United Arab Emirates and China, respectively(Chinikar S et al.,2009 ; 
Schwarz TF et al.,1995; Schwarz et al.,1997). Although very high death 
rates are reported in some series(S. Sami Karti et al. ,2004), no  death rates 
in our patients were reported and  this can be explained with better 
supportive care of the patients, and regional strain differences in CCHFV 
also play a role in the differential death rates. Nosocomial transmission of 
CCHFV through infected blood or body secretions from patients has been 
reported many times in the literature(Tantawi HH,1980; Papa A et al. ,2002; 
Colebunders R et al. ,2002; Fisher-Hoch SP et al.,1995; Weber DJ et al. 
2001;Mardani M1999-2000).In addition, there are reported cases of 
nosocomial infection in Iraq in  1979and in other parts of the world like Iran 
and Turkey(Chinikar S et al.,2009;Emad S. et al. ,2012; S. Sami Karti et al. 
,2004),but in our center, none of the  cases of nosocomial infection were  
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reported and it could be due to strict and cautious  dealing with cases of 
applying infection prevention program . 
 There are about 192 confirmed cases of CCHF which have been 
reported from different provinces in Iraq (between 1992 and Dec. 2010); 
however, five cases of nosocomial infections were recorded in 1979, 1992 
and 1996(Emad S. et al., 2012). It is of great importance to diagnose 
suspected cases of CCHF in the early stages as early as possible. Blood 
samples from suspected CCHF virus cases should be handled carefully, to 
prevent the transmission of CCHF among medical and laboratory staff, as it 
is applied in our center. 
 One of the factors that contributed to the control of this outbreak was 
the well-coordinated and efficient surveillance system for CCHF that is in 
place in Erbil and Duhok. This system is not only responsible for continuous 
monitoring of this disease, but it also deals with outbreaks. Thus, rapid and 
precise laboratory diagnosis of CCHF facilitates the control of this outbreak. 
Nevertheless, a higher level of training and precautionary measures for 
healthcare workers such as the use of isolation chambers in hospital wards, 
mask and other medical shields when contacting CCHF patients and other 
high risk professions could help in decreasing the outbreak rate in the 
endemic areas(Emad S. et al. ,2012).Patients remaining in hospital for about 
15-20 days corresponds to Convalescence period which begins about 15–20 
days after the onset of the illness(Whitehouse CA,2004; Assimina 
Zavitsanou et al. ,2009; Pierre Nabeth et al. ,2004).They were discharged 
home in good health and through a periodic telephone follow up, they 
remained healthy. 
 In conclusion, Iraq is an endemic country for CCHF and contact with 
livestock is the main source of human infection. However, through early 
referral, intensive supportive circulation using intravenous fluid, blood with 
blood product support (platelet and fresh frozen plasma), with specific 
treatment, mortality and morbidity from CCHF infection would be 
decreased.  
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